Jonathan L. Marcus, Senior Managing Director and General Counsel at CME Group Inc (NASDAQ:CME), completed a sale of 3,291 shares of Class A common stock on March 17, 2026. The shares were sold at a price of $313.37 each, producing a total transaction value of approximately $1.03 million.
The disposition was carried out pursuant to a pre-arranged Rule 10b5-1 trading plan that Marcus adopted on February 18, 2025. Following the sale, Marcus directly holds 7,192 shares of CME Group Inc.
The filing associated with the trade was amended via a Form 4/A to correct the per-share price reported for the March 17, 2026 transaction. The amended filing states the original Form 4, which was filed on March 19, 2026, contained a clerical error related to the price per share. The Form 4/A specifies that no other information in the original Form 4 has changed.
Market context noted alongside the filing highlights that CME stock has risen 21% over the past year. InvestingPro analysis referenced in the filing points out that, despite gains, the stock is currently overvalued relative to its Fair Value.
Company operational and market developments
Separate disclosures and company reports outline a number of notable developments at CME Group:
- CME reported a record open interest in its U.S. Treasury futures and options markets, reaching 36.3 million contracts. That level surpasses the previous record set in November 2025.
- The company has announced plans to launch 24/7 trading for its cryptocurrency futures and options beginning May 29, subject to regulatory approval. This initiative follows CME's reported $3 trillion in notional cryptocurrency trading volume in 2025.
- CME experienced technical issues that caused a temporary halt in trading on its Globex metals and natural gas futures and options markets. The firm has been addressing the disruptions and provided updates on pre-opening times for the affected markets.
- Analyst firm Raymond James has reiterated an Outperform rating on CME Group, maintaining a $310.00 price target.
- The same reporting noted that competitor FMX saw a notable decline in open interest.
The amended insider filing, the company's market announcements and the analyst commentary together present a mixed picture: a senior insider sale executed under an established trading plan and a company registering strong derivatives activity and strategic product expansion, alongside operational interruptions and valuation questions flagged by InvestingPro.
This account is limited to the information contained in the public filings and company disclosures referenced above; no additional claims or inferences beyond those documents are made here.
Key points
- Insider sale - Jonathan L. Marcus sold 3,291 Class A shares on March 17, 2026, at $313.37 per share, totaling $1.03 million, under a Rule 10b5-1 plan adopted February 18, 2025.
- Company activity - CME reported record U.S. Treasury futures and options open interest of 36.3 million contracts and plans round-the-clock crypto futures and options trading from May 29 pending regulatory approval.
- Operational and valuation notes - The firm faced temporary Globex trading halts for metals and natural gas markets; InvestingPro indicates the stock is currently overvalued relative to its Fair Value, while Raymond James maintains an Outperform rating with a $310.00 target.
Risks and uncertainties
- Regulatory approval - The planned May 29 start for 24/7 cryptocurrency futures and options trading is contingent on regulatory approval.
- Operational disruption - Technical problems that caused temporary halts on Globex for metals and natural gas futures and options represent an operational risk to market access and continuity.
- Valuation mismatch - InvestingPro's assessment that CME is overvalued relative to Fair Value introduces valuation uncertainty for investors assessing current exposure.